Changes

STBT5:Volunteer Assignments and Opportunities (view source)

Revision as of 11:38, 23 February 2024

1,970 bytes removed , 11:38, 23 February 2024

no edit summary

Line 16: Line 16:

!'''Date of Last Editor Review'''

!'''Notes'''

−

!

−

!

−

!

−

!

−

!

|-

|CHAPTER 2 (SOFT TISSUE TUMOURS)

−

|

−

~~----~~

−

|

−

~~----~~

−

|

−

~~----~~

−

|

−

~~----~~

−

|

−

~~----~~

|

----

Line 54: Line 39:

|[[STBT5:Lipoma|Lipoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 70: Line 50:

|[[STBT5:Lipomatosis|Lipomatosis]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 86: Line 61:

|[[STBT5:Lipomatosis_of_nerve|Lipomatosis of nerve]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 102: Line 72:

|[[STBT5:Lipoblastoma_and_lipoblastomatosis|Lipoblastoma and lipoblastomatosis]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 118: Line 83:

|[[STBT5:Angiolipoma_|Angiolipoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 134: Line 94:

|[[STBT5:Myolipoma_of_soft_tissue|Myolipoma of soft tissue]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 150: Line 105:

|[[STBT5:Chondroid_lipoma|Chondroid lipoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 166: Line 116:

|[[STBT5:Spindle_cell_lipoma_and_pleomorphic_lipoma|Spindle cell lipoma and pleomorphic lipoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 182: Line 127:

|[[STBT5:Hibernoma|Hibernoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 198: Line 138:

|[[STBT5:Atypical_spindle_cell_/_pleomorphic_lipomatous_tumour|Atypical spindle cell / pleomorphic lipomatous tumour]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 214: Line 149:

|[[STBT5:Atypical_lipomatous_tumour_/_well-differentiated_liposarcoma|Atypical lipomatous tumour / well-differentiated liposarcoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 230: Line 160:

|[[STBT5:Dedifferentiated_liposarcoma|Dedifferentiated liposarcoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 246: Line 171:

|[[STBT5:Myxoid_liposarcoma|Myxoid liposarcoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 262: Line 182:

|[[STBT5:Pleomorphic_liposarcoma_|Pleomorphic liposarcoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 278: Line 193:

|[[STBT5:Myxoid_pleomorphic_liposarcoma|Myxoid pleomorphic liposarcoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 294: Line 204:

|[[STBT5:Nodular_fasciitis|Nodular fasciitis]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 310: Line 215:

|[[STBT5:Proliferative_fasciitis_and_proliferative_myositis|Proliferative fasciitis and proliferative myositis]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 326: Line 226:

|[[STBT5:Myositis_ossificans_and_fibro-osseous_pseudotumour_of_digits|Myositis ossificans and fibro-osseous pseudotumour of digits]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 342: Line 237:

|[[STBT5:Ischaemic_fasciitis|Ischaemic fasciitis]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 358: Line 248:

|[[STBT5:Elastofibroma|Elastofibroma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 374: Line 259:

|[[STBT5:Fibrous_hamartoma_of_infancy|Fibrous hamartoma of infancy]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 390: Line 270:

|[[STBT5:Fibromatosis_colli|Fibromatosis colli]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 406: Line 281:

|[[STBT5:Juvenile_hyaline_fibromatosis|Juvenile hyaline fibromatosis]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 422: Line 292:

|[[STBT5:Inclusion_body_fibromatosis|Inclusion body fibromatosis]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 438: Line 303:

|[[STBT5:Fibroma_of_tendon_sheath|Fibroma of tendon sheath]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 454: Line 314:

|[[STBT5:Desmoplastic_fibroblastoma|Desmoplastic fibroblastoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 470: Line 325:

|[[STBT5:Myofibroblastoma|Myofibroblastoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 486: Line 336:

|[[STBT5:Calcifying_aponeurotic_fibroma|Calcifying aponeurotic fibroma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 502: Line 347:

|[[STBT5:EWSR1-SMAD3-positive_fibroblastic_tumour_(emerging)|EWSR1-SMAD3-positive fibroblastic tumour (emerging)]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 518: Line 358:

|[[STBT5:Angiomyofibroblastoma|Angiomyofibroblastoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 534: Line 369:

|[[STBT5:Cellular_angiofibroma|Cellular angiofibroma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 550: Line 380:

|[[STBT5:Angiofibroma_of_soft_tissue|Angiofibroma of soft tissue]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 566: Line 391:

|[[STBT5:Nuchal-type_fibroma|Nuchal-type fibroma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 582: Line 402:

|[[STBT5:Acral_fibromyxoma|Acral fibromyxoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 598: Line 413:

|[[STBT5:Gardner_fibroma|Gardner fibroma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 614: Line 424:

|[[STBT5:Palmar_fibromatosis_and_plantar_fibromatosis|Palmar fibromatosis and plantar fibromatosis]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 630: Line 435:

|[[STBT5:Desmoid_fibromatosis|Desmoid fibromatosis]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 646: Line 446:

|[[STBT5:Lipofibromatosis|Lipofibromatosis]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 662: Line 457:

|[[STBT5:Giant_cell_fibroblastoma|Giant cell fibroblastoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 678: Line 468:

|[[STBT5:Dermatofibrosarcoma_protuberans|Dermatofibrosarcoma protuberans]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 702: Line 487:

|

|Template added 2/21/2024

−

|

−

|

−

|

−

|

−

|

|-

|[[STBT5:Inflammatory_myofibroblastic_tumour|Inflammatory myofibroblastic tumour]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 726: Line 501:

|[[STBT5:Low-grade_myofibroblastic_sarcoma|Low-grade myofibroblastic sarcoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 742: Line 512:

|[[STBT5:Superficial_CD34-positive_fibroblastic_tumour|Superficial CD34-positive fibroblastic tumour]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 758: Line 523:

|[[STBT5:Myxoinflammatory_fibroblastic_sarcoma|Myxoinflammatory fibroblastic sarcoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 774: Line 534:

|[[STBT5:Infantile_fibrosarcoma|Infantile fibrosarcoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 790: Line 545:

|[[STBT5:Adult_fibrosarcoma|Adult fibrosarcoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 806: Line 556:

|[[STBT5:Myxofibrosarcoma|Myxofibrosarcoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 822: Line 567:

|[[STBT5:Low-grade_fibromyxoid_sarcoma|Low-grade fibromyxoid sarcoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 838: Line 578:

|[[STBT5:Sclerosing_epithelioid_fibrosarcoma|Sclerosing epithelioid fibrosarcoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 854: Line 589:

|[[STBT5:Tenosynovial_giant_cell_tumour|Tenosynovial giant cell tumour]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 870: Line 600:

|[[STBT5:Deep_fibrous_histiocytoma|Deep fibrous histiocytoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 886: Line 611:

|[[STBT5:Plexiform_fibrohistiocytic_tumour|Plexiform fibrohistiocytic tumour]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 902: Line 622:

|[[STBT5:Giant_cell_tumour_of_soft_tissue|Giant cell tumour of soft tissue]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 918: Line 633:

|[[STBT5:Synovial_haemangioma|Synovial haemangioma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 934: Line 644:

|[[STBT5:Intramuscular_angioma|Intramuscular angioma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 950: Line 655:

|[[STBT5:Arteriovenous_malformation/haemangioma|Arteriovenous malformation/haemangioma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 966: Line 666:

|[[STBT5:Venous_haemangioma|Venous haemangioma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 982: Line 677:

|[[STBT5:Anastomosing_haemangioma|Anastomosing haemangioma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 998: Line 688:

|[[STBT5:Epithelioid_haemangioma|Epithelioid haemangioma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 1,014: Line 699:

|[[STBT5:Lymphangioma_and_lymphangiomatosis|Lymphangioma and lymphangiomatosis]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 1,030: Line 710:

|[[STBT5:Tufted_angioma_and_kaposiform_haemangioendothelioma|Tufted angioma and kaposiform haemangioendothelioma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 1,046: Line 721:

|[[STBT5:Retiform_haemangioendothelioma|Retiform haemangioendothelioma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 1,062: Line 732:

|[[STBT5:Papillary_intralymphatic_angioendothelioma|Papillary intralymphatic angioendothelioma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 1,078: Line 743:

|[[STBT5:Composite_haemangioendothelioma_|Composite haemangioendothelioma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 1,094: Line 754:

|[[STBT5:Kaposi_sarcoma|Kaposi sarcoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 1,110: Line 765:

|[[STBT5:Pseudomyogenic_haemangioendothelioma|Pseudomyogenic haemangioendothelioma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 1,126: Line 776:

|[[STBT5:Epithelioid_haemangioendothelioma|Epithelioid haemangioendothelioma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 1,142: Line 787:

|[[STBT5:Angiosarcoma|Angiosarcoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 1,158: Line 798:

|[[STBT5:Glomus_tumour|Glomus tumour]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 1,174: Line 809:

|[[STBT5:Myopericytoma,_including_myofibroma|Myopericytoma, including myofibroma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 1,190: Line 820:

|[[STBT5:Angioleiomyoma|Angioleiomyoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 1,206: Line 831:

|[[STBT5:Leiomyoma|Leiomyoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 1,222: Line 842:

|[[STBT5:EBV-associated_smooth_muscle_tumour|EBV-associated smooth muscle tumour]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 1,238: Line 853:

|[[STBT5:Inflammatory_leiomyosarcoma|Inflammatory leiomyosarcoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 1,254: Line 864:

|[[STBT5:Leiomyosarcoma|Leiomyosarcoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 1,270: Line 875:

|[[STBT5:Rhabdomyoma|Rhabdomyoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 1,286: Line 886:

|[[STBT5:Embryonal_rhabdomyosarcoma|Embryonal rhabdomyosarcoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 1,302: Line 897:

|[[STBT5:Alveolar_rhabdomyosarcoma|Alveolar rhabdomyosarcoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 1,318: Line 908:

|[[STBT5:Pleomorphic_rhabdomyosarcoma|Pleomorphic rhabdomyosarcoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 1,334: Line 919:

|[[STBT5:Spindle_cell_/_sclerosing_rhabdomyosarcoma|Spindle cell / sclerosing rhabdomyosarcoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 1,350: Line 930:

|[[STBT5:Ectomesenchymoma|Ectomesenchymoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 1,366: Line 941:

|[[STBT5:Gastrointestinal_stromal_tumour|Gastrointestinal stromal tumour]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 1,382: Line 952:

|[[STBT5:Soft_tissue_chondroma|Soft tissue chondroma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 1,398: Line 963:

|[[STBT5:Extraskeletal_osteosarcoma|Extraskeletal osteosarcoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 1,414: Line 974:

|[[STBT5:Schwannoma|Schwannoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 1,430: Line 985:

|[[STBT5:Neurofibroma|Neurofibroma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 1,446: Line 996:

|[[STBT5:Perineurioma|Perineurioma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 1,462: Line 1,007:

|[[STBT5:Granular_cell_tumour|Granular cell tumour]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 1,478: Line 1,018:

|[[STBT5:Dermal_nerve_sheath_myxoma|Dermal nerve sheath myxoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 1,494: Line 1,029:

|[[STBT5:Solitary_circumscribed_neuroma|Solitary circumscribed neuroma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 1,510: Line 1,040:

|[[STBT5:Ectopic_meningioma_and_meningothelial_hamartoma|Ectopic meningioma and meningothelial hamartoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 1,526: Line 1,051:

|[[STBT5:Benign_triton_tumour_/_neuromuscular_choristoma|Benign triton tumour / neuromuscular choristoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 1,542: Line 1,062:

|[[STBT5:Hybrid_nerve_sheath_tumour|Hybrid nerve sheath tumour]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 1,558: Line 1,073:

|[[STBT5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 1,574: Line 1,084:

|[[STBT5:Malignant_melanotic_nerve_sheath_tumour|Malignant melanotic nerve sheath tumour]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 1,590: Line 1,095:

|[[STBT5:Intramuscular_myxoma|Intramuscular myxoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 1,606: Line 1,106:

|[[STBT5:Juxta-articular_myxoma|Juxta-articular myxoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 1,622: Line 1,117:

|[[STBT5:Deep_(aggressive)_angiomyxoma|Deep (aggressive) angiomyxoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 1,638: Line 1,128:

|[[STBT5:Atypical_fibroxanthoma|Atypical fibroxanthoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 1,654: Line 1,139:

|[[STBT5:Angiomatoid_fibrous_histiocytoma|Angiomatoid fibrous histiocytoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 1,670: Line 1,150:

|[[STBT5:Ossifying_fibromyxoid_tumour|Ossifying fibromyxoid tumour]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 1,686: Line 1,161:

|[[STBT5:Myoepithelioma,_myoepithelial_carcinoma,_and_mixed_tumour|Myoepithelioma, myoepithelial carcinoma, and mixed tumour]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 1,702: Line 1,172:

|[[STBT5:Pleomorphic_hyalinizing_angiectatic_tumour_of_soft_parts|Pleomorphic hyalinizing angiectatic tumour of soft parts]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 1,718: Line 1,183:

|[[STBT5:Haemosiderotic_fibrolipomatous_tumour|Haemosiderotic fibrolipomatous tumour]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 1,734: Line 1,194:

|[[STBT5:Phosphaturic_mesenchymal_tumour|Phosphaturic mesenchymal tumour]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 1,756: Line 1,211:

|

|Alanna Church

−

|

−

|

−

|

−

|

−

|

Line 1,766: Line 1,216:

|[[STBT5:Synovial_sarcoma|Synovial sarcoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 1,782: Line 1,227:

|[[STBT5:Epithelioid_sarcoma|Epithelioid sarcoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 1,798: Line 1,238:

|[[STBT5:Alveolar_soft_part_sarcoma|Alveolar soft part sarcoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 1,814: Line 1,249:

|[[STBT5:Clear_cell_sarcoma_of_soft_tissue|Clear cell sarcoma of soft tissue]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 1,830: Line 1,260:

|[[STBT5:Extraskeletal_myxoid_chondrosarcoma_|Extraskeletal myxoid chondrosarcoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 1,846: Line 1,271:

|[[STBT5:Desmoplastic_small_round_cell_tumour|Desmoplastic small round cell tumour]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 1,862: Line 1,282:

|[[STBT5:Extrarenal_rhabdoid_tumour|Extrarenal rhabdoid tumour]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 1,878: Line 1,293:

|[[STBT5:PEComa|PEComa]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 1,894: Line 1,304:

|[[STBT5:Intimal_sarcoma|Intimal sarcoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 1,910: Line 1,315:

|[[STBT5:Undifferentiated_sarcoma|Undifferentiated sarcoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 1,925: Line 1,325:

|-

|CHAPTER 3 (UNDIFFERENTIATED SMALL ROUND CELL SARCOMAS OF BONE AND SOFT TISSUE)

−

|

−

~~----~~

−

|

−

~~----~~

−

|

−

~~----~~

−

|

−

~~----~~

−

|

−

~~----~~

|

----

Line 1,964: Line 1,354:

|

|2021 template added

−

|

−

|

−

|

−

|

−

|

|-

|[[STBT5:Round_cell_sarcoma_with_EWSR1-non-ETS_fusions|Round cell sarcoma with EWSR1-non-ETS fusions]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 1,988: Line 1,368:

|[[STBT5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 2,004: Line 1,379:

|[[STBT5:Sarcoma_with_BCOR_genetic_alterations|Sarcoma with BCOR genetic alterations]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 2,019: Line 1,389:

|-

|CHAPTER 4 (BONE TUMOURS)

−

|

−

~~----~~

−

|

−

~~----~~

−

|

−

~~----~~

−

|

−

~~----~~

−

|

−

~~----~~

|

----

Line 2,050: Line 1,410:

|[[STBT5:Subungual_exostosis|Subungual exostosis]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 2,066: Line 1,421:

|[[STBT5:Bizarre_parosteal_osteochondromatous_proliferation|Bizarre parosteal osteochondromatous proliferation]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 2,082: Line 1,432:

|[[STBT5:Periosteal_chondroma|Periosteal chondroma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 2,098: Line 1,443:

|[[STBT5:Enchondroma|Enchondroma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 2,114: Line 1,454:

|[[STBT5:Osteochondroma|Osteochondroma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 2,130: Line 1,465:

|[[STBT5:Chondroblastoma|Chondroblastoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 2,146: Line 1,476:

|[[STBT5:Chondromyxoid_fibroma|Chondromyxoid fibroma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 2,162: Line 1,487:

|[[STBT5:Osteochondromyxoma|Osteochondromyxoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 2,178: Line 1,498:

|[[STBT5:Synovial_chondromatosis|Synovial chondromatosis]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 2,194: Line 1,509:

|[[STBT5:Central_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Central atypical cartilaginous tumour / chondrosarcoma, grade 1]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 2,210: Line 1,520:

|[[STBT5:Secondary_peripheral_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Secondary peripheral atypical cartilaginous tumour / chondrosarcoma, grade 1]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 2,226: Line 1,531:

|[[STBT5:Central_chondrosarcoma,_grades_2_and_3|Central chondrosarcoma, grades 2 and 3]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 2,242: Line 1,542:

|[[STBT5:Secondary_peripheral_chondrosarcoma,_grades_2_and_3|Secondary peripheral chondrosarcoma, grades 2 and 3]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 2,258: Line 1,553:

|[[STBT5:Periosteal_chondrosarcoma|Periosteal chondrosarcoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 2,274: Line 1,564:

|[[STBT5:Clear_cell_chondrosarcoma|Clear cell chondrosarcoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 2,290: Line 1,575:

|[[STBT5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 2,306: Line 1,586:

|[[STBT5:Dedifferentiated_chondrosarcoma_|Dedifferentiated chondrosarcoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 2,322: Line 1,597:

|[[STBT5:Osteoma|Osteoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 2,338: Line 1,608:

|[[STBT5:Osteoid_osteoma_|Osteoid osteoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 2,354: Line 1,619:

|[[STBT5:Osteoblastoma_|Osteoblastoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 2,370: Line 1,630:

|[[STBT5:Low-grade_central_osteosarcoma|Low-grade central osteosarcoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 2,386: Line 1,641:

|[[STBT5:Osteosarcoma|Osteosarcoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 2,402: Line 1,652:

|[[STBT5:Parosteal_osteosarcoma_|Parosteal osteosarcoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 2,418: Line 1,663:

|[[STBT5:Periosteal_osteosarcoma_|Periosteal osteosarcoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 2,434: Line 1,674:

|[[STBT5:High-grade_surface_osteosarcoma|High-grade surface osteosarcoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 2,450: Line 1,685:

|[[STBT5:Secondary_osteosarcoma|Secondary osteosarcoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 2,466: Line 1,696:

|[[STBT5:Desmoplastic_fibroma_of_bone|Desmoplastic fibroma of bone]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 2,482: Line 1,707:

|[[STBT5:Fibrosarcoma_of_bone|Fibrosarcoma of bone]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 2,498: Line 1,718:

|[[STBT5:Haemangioma_of_bone|Haemangioma of bone]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 2,514: Line 1,729:

|[[STBT5:Epithelioid_haemangioma_of_bone|Epithelioid haemangioma of bone]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 2,530: Line 1,740:

|[[STBT5:Epithelioid_haemangioendothelioma_of_bone|Epithelioid haemangioendothelioma of bone]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 2,546: Line 1,751:

|[[STBT5:Angiosarcoma_of_bone|Angiosarcoma of bone]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 2,562: Line 1,762:

|[[STBT5:Aneurysmal_bone_cyst|Aneurysmal bone cyst]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 2,578: Line 1,773:

|[[STBT5:Giant_cell_tumour_of_bone_|Giant cell tumour of bone]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 2,594: Line 1,784:

|[[STBT5:Non-ossifying_fibroma|Non-ossifying fibroma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 2,610: Line 1,795:

|[[STBT5:Benign_notochordal_cell_tumour_|Benign notochordal cell tumour]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 2,626: Line 1,806:

|[[STBT5:Conventional_chordoma|Conventional chordoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 2,642: Line 1,817:

|[[STBT5:Dedifferentiated_chordoma|Dedifferentiated chordoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 2,658: Line 1,828:

|[[STBT5:Poorly_differentiated_chordoma|Poorly differentiated chordoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 2,674: Line 1,839:

|[[STBT5:Chondromesenchymal_hamartoma_of_chest_wall|Chondromesenchymal hamartoma of chest wall]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 2,690: Line 1,850:

|[[STBT5:Osteofibrous_dysplasia_|Osteofibrous dysplasia]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 2,706: Line 1,861:

|[[STBT5:Adamantinoma_of_long_bones|Adamantinoma of long bones]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 2,722: Line 1,872:

|[[STBT5:Simple_bone_cyst|Simple bone cyst]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 2,738: Line 1,883:

|[[STBT5:Fibrocartilaginous_mesenchymoma|Fibrocartilaginous mesenchymoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 2,754: Line 1,894:

|[[STBT5:Fibrous_dysplasia|Fibrous dysplasia]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 2,770: Line 1,905:

|[[STBT5:Lipoma_and_hibernoma_of_bone|Lipoma and hibernoma of bone]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 2,786: Line 1,916:

|[[STBT5:Leiomyosarcoma_of_bone|Leiomyosarcoma of bone]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 2,802: Line 1,927:

|[[STBT5:Undifferentiated_pleomorphic_sarcoma|Undifferentiated pleomorphic sarcoma]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 2,818: Line 1,938:

|[[STBT5:Bone_metastases|Bone metastases]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 2,834: Line 1,949:

|[[STBT5:Solitary_plasmacytoma_of_bone|Solitary plasmacytoma of bone]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 2,850: Line 1,960:

|[[STBT5:Primary_non-Hodgkin_lymphoma_of_bone|Primary non-Hodgkin lymphoma of bone]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 2,866: Line 1,971:

|[[STBT5:Langerhans_cell_histiocytosis_|Langerhans cell histiocytosis]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 2,882: Line 1,982:

|[[STBT5:Erdheim-Chester_disease_|Erdheim-Chester disease]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 2,898: Line 1,993:

|[[STBT5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 2,913: Line 2,003:

|-

|CHAPTER 5 (GENETIC TUMOUR SYNDROMES OF SOFT TISSUE AND BONE)

−

|

−

~~----~~

−

|

−

~~----~~

−

|

−

~~----~~

−

|

−

~~----~~

−

|

−

~~----~~

|

----

Line 2,944: Line 2,024:

|[[STBT5:Enchondromatosis|Enchondromatosis]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 2,960: Line 2,035:

|[[STBT5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 2,976: Line 2,046:

|[[STBT5:McCune-Albright_syndrome|McCune-Albright syndrome]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 2,992: Line 2,057:

|[[STBT5:Multiple_osteochondromas|Multiple osteochondromas]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 3,008: Line 2,068:

|[[STBT5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 3,024: Line 2,079:

|[[STBT5:Rothmund-Thomson_syndrome|Rothmund-Thomson syndrome]]

|Disease

−

|

−

|

−

|

−

|

−

|

Line 3,040: Line 2,090:

|[[STBT5:Werner_syndrome|Werner syndrome]]

|Disease

−

|

−

|

−

|

−

|

−

|

Jennelleh

Bureaucrats, Editors, Administrators

3,881

edits